We provide you with 20 years of free, institutional-grade data for AGRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AGRX. Explore the full financial landscape of AGRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Agile Therapeutics, Inc(NASDAQ:AGRX) 
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pi...
Website: http://www.agiletherapeutics.com
Founded: 1997
Full Time Employees: 15
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about AGRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.